Alcon agrees to purchase LENSAR

(Image Credit: AdobeStock/piter2121)

Alcon and LENSAR have entered into an agreement under which Alcon intends to acquire LENSAR. The acquisition also includes the ALLY Robotic Cataract Laser Treatment System, LENSAR’s proprietary Streamline software technology, and LENSAR legacy laser system.

The companies noted that under the terms of the agreement, Alcon will purchase all outstanding shares of LENSAR for $14.00 per share in cash (a value of approximately $356 million). An additional non-tradeable contingent value right offering up to $2.75 per share in cash, conditioned on achievement of 614,000 cumulative procedures with LENSAR’s products between January 1, 2026, and December 31, 2027, was also noted.

Both David Endicott, CEO of Alcon, and Nick Curtis, CEO of LENSAR, commented on the purchase in a press release from the company.

“We are excited for the opportunity to bring LENSAR’s unique next-generation technologies and intellectual property into our innovative, market-leading equipment portfolio,” said Endicott. “By leveraging our global footprint, we have the opportunity to deliver the benefits of advanced femtosecond laser technology to many more surgeons around the world and continue to improve efficiency in cataract surgery.”

“Our focus has been on providing surgeons with breakthrough laser technology in cataract surgery for today and tomorrow,” said Curtis. “Thanks to the continued passion and commitment of LENSAR associates, customers, and our investors, we are excited about the potential Alcon has to advance the industry in next-generation laser technology for refractive cataract surgery, furthering our and their mission to meet the needs of both surgeons and their cataract patients.”

The transaction is anticipated to close in mid-to-late 2025, according to the company

References:

1. Alcon agrees to acquire LENSAR, Inc. Alcon. Published March 24, 2025. Accessed March 24, 2025. https://investor.alcon.com/news-and-events/press-releases/news-details/2025/Alcon-Agrees-to-Acquire-LENSAR-Inc-/default.aspx